T. Rowe Price Investment Management’s Elevance Health ELV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.4M | Buy |
3,588
+1,267
| +55% | +$493K | ﹤0.01% | 614 |
|
|
2025
Q1 | $1.01M | Buy |
2,321
+983
| +73% | +$428K | ﹤0.01% | 615 |
|
|
2024
Q4 | $494K | Sell |
1,338
-30,321
| -96% | -$11.2M | ﹤0.01% | 617 |
|
|
2024
Q3 | $16.5M | Buy |
31,659
+10,448
| +49% | +$5.43M | 0.01% | 534 |
|
|
2024
Q2 | $11.5M | Buy |
21,211
+5,114
| +32% | +$2.77M | 0.01% | 541 |
|
|
2024
Q1 | $8.35M | Buy |
16,097
+7,048
| +78% | +$3.65M | 0.01% | 545 |
|
|
2023
Q4 | $4.27M | Buy |
9,049
+5,688
| +169% | +$2.68M | ﹤0.01% | 531 |
|
|
2023
Q3 | $1.46M | Buy |
3,361
+2,646
| +370% | +$1.15M | ﹤0.01% | 550 |
|
|
2023
Q2 | $318K | Buy |
+715
| New | +$318K | ﹤0.01% | 553 |
|